Table 3.
Percentage of US adults meeting the definition for hypertension and recommended antihypertensive medication according to the 2017 ACC/AHA guideline and the JNC7 guideline based on the 2011–2014 National Health and Nutrition Examination Survey.
| 2017 ACC/AHA guideline | JNC7 guideline | Difference (2017 ACC/AHA but not JNC7) |
||||
|---|---|---|---|---|---|---|
| Hypertension | Recommended antihypertensive medication |
Hypertension | Recommended antihypertensive medication |
Hypertension | Recommended antihypertensive medication |
|
| Overall | 45.6 (43.6, 47.6) |
36.2 (34.2, 38.2) |
31.9 (30.1, 33.7) |
34.3 (32.5, 36.2) |
13.7 (12.7, 14.9) |
1.9 (1.5, 2.3) |
| Age group | ||||||
| 20–44 | 24.0 (21.8, 26.2) |
12.5 (11.2, 13.9) |
10.5 (9.4, 11.7) |
12.2 (10.9, 13.6) |
13.4 (12.0, 15.0) |
0.3 (0.1, 0.5) |
| 45–54 | 47.1 (44.4, 49.8) |
33.4 (30.8, 36.1) |
29.5 (27.0, 32.2) |
32.7 (30.1, 35.4) |
17.6 (15.1, 20.4) |
0.7 (0.4, 1.2) |
| 55–64 | 66.6 (63.6, 69.5) |
58.2 (54.9, 61.4) |
52.4 (49.1, 55.7) |
55.0 (62.0, 58.0) |
14.2 (12.1, 16.6) |
3.2 (2.1, 4.7) |
| 65–74 | 75.6 (73.4, 77.6) |
74.1 (71.4, 76.6) |
63.6 (60.2, 66.9) |
66.9 (63.7, 69.9) |
12.0 (9.4, 15.2) |
7.2 (5.2, 10.0) |
| 75+ | 82.3 (79.2, 85.0) |
82.3 (79.2, 85.0) |
75.1 (71.9, 78.1) |
78.5 (74.7, 81.8) |
7.1 (5.6, 9.0) |
3.8 (2.5, 5.6) |
| Men | 48.6 (45.9, 51.3) |
37.3 (34.9, 39.8) |
32.0 (29.8, 34.3) |
34.8 (32.4, 37.3) |
16.6 (15.0, 18.3) |
2.5 (2.0, 3.1) |
| Women | 42.9 (40.7, 45.1) |
35.1 (33.1, 37.3) |
31.8 (29.8, 33.8) |
33.8 (31.8, 35.9) |
11.1 (9.8, 12.5) |
1.3 (0.9, 1.9) |
| Race-ethnicity | ||||||
| Non-Hispanic white | 47.3 (44.5, 50.0) |
37.9 (35.3, 40.6) |
33.4 (31.1, 35.8) |
35.7 (33.3, 38.2) |
13.8 (12.4, 15.4) |
2.2 (1.6, 2.8) |
| Non-Hispanic black | 54.9 (52.5, 57.3) |
44.8 (42.5, 47.0) |
41.0 (39.0, 43.1) |
43.6 (41.4, 45.8) |
13.9 (12.2, 15.7) |
1.2 (0.8, 1.8) |
| Non-Hispanic Asian | 36.7 (32.6, 40.9) |
27.9 (24.2, 32.0) |
24.4 (21.1, 28.2) |
26.8 (23.1, 30.8) |
12.2 (10.4, 14.3) |
1.1 (0.6, 2.0) |
| Hispanic | 34.4 (31.8, 37.1) |
25.5 (23.0, 28.1) |
21.1 (18.7, 23.8) |
24.3 (21.8, 26.9) |
13.3 (11.7, 15.1) |
1.2 (0.9, 1.6) |
| Risk categories | ||||||
| <5% | 27.4 (25.6, 29.3) |
14.6 (13.3, 16.0) |
13.2 (12.0, 14.5) |
14.6 (13.3, 16.0) |
14.2 (13.1, 15.4) |
0 |
| 5% to <10% | 61.4 (57.2, 65.3) |
48.4 (44.5, 52.3) |
42.7 (38.5, 47.1) |
46.6 (42.7, 50.5) |
18.6 (15.2, 22.6) |
1.8 (0.9, 3.6) |
| 10% to <20% | 78.2 (74.7, 81.4) |
78.2 (74.7, 81.4) |
63.6 (58.4, 68.5) |
68.3 (63.5, 72.7) |
14.6 (11.5, 18.4) |
9.9 (7.7, 12.7) |
| ≥20% | 85.7 (82.7, 88.2) |
85.7 (82.7, 88.2) |
77.3 (74.0, 80.3) |
81.4 (77.7, 84.6) |
8.4 (7.1, 9.8) |
4.3 (3.1, 5.8) |
| History of CVD | 79.3 (75.6, 82.6) |
79.3 (75.6, 82.6) |
72.1 (68.8, 75.3) |
75.7 (72.7, 78.4) |
7.2 (5.0, 10.3) |
3.7 (2.1, 6.2) |
Numbers in table are percentage of US adults (95% confidence interval)
See Table 1 for the definitions of hypertension and antihypertensive medication treatment recommendations.
2017 ACC/AHA guideline - 2017 American College of Cardiology/American Heart Association Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.
JNC7 guideline - Seventh Report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure
CVD – cardiovascular disease